May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Identification of Autoantibody Biomarkers in Sera From Patients With Age-Related Macular Degeneration
Author Affiliations & Notes
  • K. Morohoshi
    Ophthalmology, Emory University, Atlanta, Georgia
    Dobbs Ocuar Immunology Laboratory, Atlanta, Georgia
  • N. Patel
    Retinal Research Unit, King's College Hospital and School of Medicine, London, United Kingdom
  • M. Ohbayashi
    Ophthalmology, Emory University, Atlanta, Georgia
    Dobbs Ocuar Immunology Laboratory, Atlanta, Georgia
  • V. Chong
    Retinal Research Unit, King's College Hospital and School of Medicine, London, United Kingdom
  • A. C. Bird
    Ocular Immunology, Institute of Ophthalmology, University College of London, London, United Kingdom
  • S. J. Ono
    Ophthalmology, Emory University, Atlanta, Georgia
    Dobbs Ocuar Immunology Laboratory, Atlanta, Georgia
  • Footnotes
    Commercial Relationships  K. Morohoshi, None; N. Patel, None; M. Ohbayashi, None; V. Chong, None; A.C. Bird, None; S.J. Ono, None.
  • Footnotes
    Support  the Dobbs Foundation
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5154. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Morohoshi, N. Patel, M. Ohbayashi, V. Chong, A. C. Bird, S. J. Ono; Identification of Autoantibody Biomarkers in Sera From Patients With Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5154.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To reveal serum autoantibodies associated with age-related macular degeneration (AMD) and identify biomarkers for progression of AMD.

Methods: : Blood was collected from patients with AMD and age-matched normal donors from the Kings College Hospital in London. Serum samples from patients with choroidal neovascularization (CNV), patients with age-related maculopathy (ARM), and normal, healthy controls were incubated with an antigen microarray printed with 82 kinds of antigens to detect the reactivity of IgG and IgM antoantibodies. Cut-off values for IgG/IgM ratios were determined by receiver operating characteristic (ROC) analysis.

Results: : Sera from the AMD group contained high levels of IgG and IgM autoantibodies to numerous antigens including cyclic nucleotide phosphodiesterase and proliferating cell nuclear antigen, when compared to the normal group. Differences in antigen profiles were also observed between different stages of the disease, i.e. between CNV and ARM. Moreover, the IgG/IgM ratio for antibodies to several systemic antigens correlated with the stage of AMD.

Conclusions: : Sera from patients with AMD contain specific autoantibodies which may be used as biomarkers for AMD, and the IgG/M ratio for these autoantibodies might allow better monitoring of AMD progression.

Keywords: age-related macular degeneration • proteomics • autoimmune disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×